Spica Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RadioMedix and Orano Med Complete Patient Enrolment in Phase II Trial of Targeted Alpha-Emitter AlphaMedix in Neuroendocrine Cancers

Trial's Objective Response Rate Endpoint Already Achieved RadioMedix and Orano Med, two clinical stage radiopharmaceutical companies, today announced that the last patient has been dosed in the Phase

United statesIzabela tworowskaJulien dodetEbrahim delpassandMike sinclairRadiomedix incSpica centerObjective response rate endpoint alreadyOrano medChief executive officerTargeted alpha emitter therapyNorth americaMedical officerGefallene big techs

Fusion Pharmaceuticals to Acquire Phase 2 Program for 225Ac-PSMA I&T, a Radiopharmaceutical Targeting Metastatic Castrate Resistant Prostate Cancer

/PRNewswire/ Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) ("Fusion"), a clinical-stage oncology company focused on developing next-generation targeted alpha.

United statesEbrahim delpassandJohn valliantAmanda crayFusion pharmaceuticals incMorgan stanleySpica centerDeerfield management companyLaborde professor for cancer researchPrnewswire fusion pharmaceuticals incRadiomedix incFusion pharmaceuticalsWoodline master fundNiowave incTulane cancer centerExchange commission

RadioMedix announces a $40 million Series A financing for

HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company.

United statesEbrahim delpassandMichael lee chinSpica centerRadiomedix or companyRadiomedix incPortland investment counsel incPortland investment counselChief executive officerExecutive chairmanTargeted alpha therapyRadiomedix incPress releaseSeriesa financingTargeted alpha emitter therapyEad 212

Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme

Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEbrahim delpassandKostenloser wertpapierhandelIzabela tworowskaJamal temsamaniMichel khrestchatiskyElodie dormesAlexandre tokaySpica centerBusiness development srInstitute for neurophysiopathologyDrug development of vectDrug discovery centerAix marseille universityNuclear oncology center houstonRadiomedix inc

Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme

Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme
cadillacnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadillacnews.com Daily Mail and Mail on Sunday newspapers.

United statesEbrahim delpassandIzabela tworowskaJamal temsamaniMichel khrestchatiskyElodie dormesAlexandre tokaySpica centerBusiness development srInstitute for neurophysiopathologyDrug development of vectDrug discovery centerAix marseille universityNuclear oncology center houstonRadiomedix incInvestigational new drug